Congress phases out 'forever chemicals' in consumer products, banning PFAS from food packaging and t

What it does

This bill phases out nonessential uses of 'forever chemicals' (PFAS) over 10 years, banning them from consumer products on accelerated timelines (1–5 years depending on product type) and requiring manufacturers to report annual use and environmental releases. It establishes a National Academies review to identify which uses are truly essential, and prohibits all detectable releases of PFAS into the environment by year 10. Citizens gain protection from widespread PFAS contamination in water, food, and consumer goods; manufacturers face compliance costs and must transition to safer alternatives.

Why we flagged it

The bill's core mechanism is a mandatory phaseout of nonessential PFAS uses and all detectable environmental releases, with accelerated timelines for consumer products. It is a public-health-driven chemical regulation, not a market-driven or industry-specific carve-out.

What the text implies

• Section 202 (Actions under State law for damages) may expand private litigation rights against PFAS manufacturers and users, potentially creating significant liability exposure and settlement costs for companies—a material financial consequence not obvious from the title.
• Section 203 (Bankruptcy provision for persistent, bioaccumulative, and toxic chemicals defendants) may alter bankruptcy treatment of PFAS-related claims, potentially subordinating or limiting discharge of environmental liabilities—a structural change to creditor priority.
• The 'essential use' designation process (Section 102(c)) places the burden of proof on petitioners to prove a use is essential; this inverts the typical regulatory default and may result in discontinuation of uses that lack robust scientific documentation, even if they serve critical functions.
• Federal procurement phaseout (Section 103(b)) may create supply-chain disruption for military and defense applications if PFAS-containing products (e.g., firefighting foam, protective coatings) lack approved alternatives, potentially affecting national security readiness.
• The bill authorizes transfer of remaining PFAS stocks to research consortia and DOE labs (Sections 102(b)(1)(B), 105(b)), creating a potential long-term research infrastructure dependent on PFAS availability and raising questions about how 'research' uses will be monitored and eventually eliminated.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens are protected from PFAS contamination in drinking water, food packaging, textiles, and consumer products—a significant public health gain. The bill restricts manufacturers' freedom to use cheap persistent chemicals, but that restriction protects citizens from bioaccumulative toxins linked to cancer, immune suppression, and developmental harm.

Who stands to gain

• Chemical manufacturers producing PFAS alternatives and substitutes
• Environmental remediation and water treatment companies
• Research institutions and Centers of Excellence (funded for PFAS research)
• Consulting and compliance firms advising manufacturers on phaseout plans

Named in the bill

Environmental Protection Agency (EPA), National Academies of Sciences, Engineering, and Medicine, Department of Energy (National Laboratories), Federal agencies (procurement phaseout), Manufacturers and users of PFAS, Centers of Excellence (research), State environmental agencies

Where it stands

7 cosponsors: 7 Democrats.

• Mar 19, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 19, 2026 — Referred to House Committee on Armed Services and House Committee on Transportation and Infrastructure · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $342,577 in lobbying spend. A filing names 8 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

Betty McCollum, the sponsor, reported $498,300 in PAC receipts in the 2026 cycle.

• Air-conditioning, Heating, and Refrigeration Institute — $292,577 on 1 filing
• Air Conditioning, Heating and Refrigeration Institute (ahri) — $30,000 on 1 filing
• Covestro LLC — $20,000 on 1 filing

Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.